Equities

Jamieson Wellness Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Jamieson Wellness Inc

Actions
  • Price (EUR)22.80
  • Today's Change0.20 / 0.88%
  • Shares traded--
  • 1 Year change+7.55%
  • Beta0.8913
Data delayed at least 15 minutes, as of Feb 16 2026 15:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Jamieson Wellness Inc. is a Canada-based company engaged in the manufacturing, development, distribution, sales and marketing of branded and customer branded health products for humans, including vitamins, herbal and mineral nutritional supplements. Its brands are available in more than 50 countries globally. It offers a variety of vitamins, minerals and supplements (VMS) products to consumers with its youtheory, Progressive, Smart Solutions, Iron Vegan and Precision brands. Its product portfolio is specifically curated to help maintain overall health with daily multivitamins for all age groups, letter vitamins, digestive, heart health and immune support formulas. It offers a variety of products to support women’s hormone health and beauty from within, and proteins and other sports nutrition products. It provides vitamins through gummies, chewable tablets, powders, sprays and more. Its manufacturing facilities are in Windsor, Ontario, Toronto, Ontario and Irvine, California.

  • Revenue in CAD (TTM)789.18m
  • Net income in CAD62.41m
  • Incorporated2014
  • Employees1.34k
  • Location
    Jamieson Wellness Inc1 Adelaide Street East, Suite 2200TORONTO M5C 2V9CanadaCAN
  • Phone+1 (416) 960-0052
  • Fax+1 (416) 960-0052
  • Websitehttps://www.jamiesonwellness.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.